High ceruloplasmin levels are associated with obsessive compulsive disorder: a case control study

Author:

Virit Osman,Selek Salih,Bulut Mahmut,Savas Haluk Asuman,Celik Hakim,Erel Ozcan,Herken Hasan

Abstract

Abstract Background Alterations in ceruloplasmin are currently assumed as one of the mechanisms underlying the development of a number of neurodegenerative disorders. Several studies indicate that elevated serum ceruloplasmin levels may play a role in schizophrenia by exacerbating or perpetuating dopaminergic dysregulation. No study investigating the relationship between ceruloplasmin and obsessive-compulsive disorder (OCD) has been published to date. Nowadays OCD is increasingly speculated to be a different disorder than other anxiety disorders, and rather is considered to be more similar to psychotic disorders. The objective of this study to explore whether there is an association of ceruloplasmin with OCD as in schizophrenia. Method 26 pure OCD and 9 co-morbid OCD patients from Gaziantep University Sahinbey Research Hospital, Psychiatry Clinics, diagnosed according to the DSM IV and 40 healthy controls were included in the study. Blood samples were collected; ceruloplasmin levels were measured. Results The mean ceruloplasmin level in pure OCD patients, co-morbid OCD patients, and control group persons were 544.46 ± 26.53, 424.43 ± 31.50 and 222.35 ± 8.88 U/L respectively. Results of all 3 groups differ significantly. Positive predictive value of ceruloplasmin for that cut-off point is 31/31 (100%) and negative predictive value is 40/44 (91%) in our group. Conclusion Although the nature of relationship is not clear there was an association between ceruloplasmin levels and OCD in our study.

Publisher

Springer Science and Business Media LLC

Subject

Behavioral Neuroscience,Biological Psychiatry,Cognitive Neuroscience,General Medicine

Reference36 articles.

1. Vassiliev V, Harris ZL, Zatta P: Ceruloplasmin in neurodegenerative diseases. Brain Res Brain Res Rev. 2005, 49: 633-640. 10.1016/j.brainresrev.2005.03.003.

2. Puzynski S: Investigations on ceruloplasmin in chronic schizophrenia. Pol Med J. 1966, 5: 1484-1491.

3. Alias AG, Vijayan N, Nair DS, Sukumaran M: Serum ceruloplasmin in schizophrenia: significant increase in acute cases especially in catatonia. Biol Psychiatry. 1972, 4: 231-238.

4. Giner J, Morell M, Osorio C: Serum levels of ceruloplasmin as an index of the clinical evolution in schizophrenic patients. Rev Esp Fisiol. 1972, 28: 39-42.

5. Chugh T, Dhingra R, Gulati R, Bathla J: Copper metabolism in schizophrenia. Indian J Med Res. 1973, 61: 1147-1152.

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3